James F. Reddoch

Insider Reports History

Entity
Individual
Location
C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James F. Reddoch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP & Chief Scientific Officer Class A Ordinary Shares 821K $22.6M $27.55 Sep 28, 2022 By Reddoch RPI LLC
Royalty Pharma plc EVP & Chief Scientific Officer Class A Ordinary Shares 25K $690K $27.55 Sep 28, 2022 By IRA
Royalty Pharma plc EVP & Chief Scientific Officer LP interests in RPI US Partners 2019, LP 479K Aug 12, 2022 By Reddoch RPI LLC

Insider Reports Filed by James F. Reddoch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc Sep 28, 2022 2 -$4.12M 4 Sep 30, 2022 EVP & Chief Scientific Officer
RPRX Royalty Pharma plc Jun 8, 2022 1 -$4.16M 4 Jun 10, 2022 EVP & Chief Scientific Officer
RPRX Royalty Pharma plc May 27, 2022 1 -$3.08M 4 May 31, 2022 EVP & Chief Scientific Officer
RPRX Royalty Pharma plc May 19, 2022 1 -$3.03M 4 May 23, 2022 EVP & Chief Scientific Officer
RPRX Royalty Pharma plc Sep 10, 2021 1 $0 4 Dec 30, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jul 26, 2021 1 -$356K 4 Jul 27, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jul 26, 2021 1 -$356K 4 Jul 27, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jul 12, 2021 3 -$753K 4 Jul 14, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jul 6, 2021 3 -$3.09M 4 Jul 8, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jun 4, 2021 4 -$9.11M 4 Jun 8, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc Jun 2, 2021 1 -$2.11M 4 Jun 4, 2021 EVP, Research & Investments
RPRX Royalty Pharma plc May 7, 2021 2 $0 4 May 11, 2021 EVP, Research & Investments